acc00251 |
Alpha-endosulfine |
phosphorylation |
Tyr64 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00252 |
Catenin delta-1 |
phosphorylation |
Tyr228 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00253 |
Catenin delta-1 |
phosphorylation |
Tyr213 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00254 |
Catenin delta-1 |
phosphorylation |
Tyr904 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00255 |
Catenin delta-1 |
phosphorylation |
Tyr248 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00256 |
Claudin-7 |
phosphorylation |
Tyr210 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00257 |
Epidermal growth factor receptor |
phosphorylation |
Tyr1197 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00258 |
Epidermal growth factor receptor |
phosphorylation |
Tyr998 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00259 |
Anion exchange protein 2 |
phosphorylation |
Tyr66 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00260 |
"Keratin, type I cytoskeletal 18" |
phosphorylation |
Tyr13 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00261 |
Cyclin-dependent kinase 1 |
phosphorylation |
Tyr15 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Positive |
5.0 |
PXD031346
|
acc00262 |
Annexin A2 |
phosphorylation |
Tyr238 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00263 |
Putative annexin A2-like protein |
phosphorylation |
Tyr238 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00264 |
Hepatocyte growth factor receptor |
phosphorylation |
Tyr1234 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00265 |
Hepatocyte growth factor receptor |
phosphorylation |
Tyr1235 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00266 |
Tubulin alpha-4A chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00267 |
Tubulin alpha-8 chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00268 |
Dephenylalaninated tubulin alpha-8 chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00269 |
Tubulin alpha-1C chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00270 |
Detyrosinated tubulin alpha-1C chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00271 |
Tubulin alpha-3D chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00272 |
Detyrosinated tubulin alpha-3D chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00273 |
Tubulin alpha-3C chain |
phosphorylation |
Tyr224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00274 |
Protein 4.1 |
phosphorylation |
Tyr660 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00275 |
Mucin-1 |
phosphorylation |
Tyr1229 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00276 |
Integrin beta-4 |
phosphorylation |
Tyr1492 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00277 |
Syndecan-1 |
phosphorylation |
Tyr309 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00278 |
Plasma membrane calcium-transporting ATPase 1 |
phosphorylation |
Tyr1129 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00279 |
Plasma membrane calcium-transporting ATPase 2 |
phosphorylation |
Tyr1152 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00280 |
Receptor tyrosine-protein kinase erbB-3 |
phosphorylation |
Tyr1307 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00281 |
E3 ubiquitin-protein ligase CBL |
phosphorylation |
Tyr700 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00282 |
Eukaryotic translation initiation factor 4B |
phosphorylation |
Tyr316 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00283 |
Ephrin type-A receptor 2 |
phosphorylation |
Tyr594 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00284 |
Serpin B4 |
phosphorylation |
Tyr207 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Positive |
5.0 |
PXD031346
|
acc00285 |
Serpin B3 |
phosphorylation |
Tyr207 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Positive |
5.0 |
PXD031346
|
acc00286 |
Non-receptor tyrosine-protein kinase TYK2 |
phosphorylation |
Tyr1054 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00287 |
RNA-binding protein FUS |
phosphorylation |
Tyr468 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00288 |
Transgelin-2 |
phosphorylation |
Tyr192 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00289 |
Transgelin-3 |
phosphorylation |
Tyr192 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00290 |
Afadin |
phosphorylation |
Tyr584 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00291 |
Amyloid beta precursor like protein 2 |
phosphorylation |
Tyr750 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00292 |
Tight junction protein ZO-1 |
phosphorylation |
Tyr1195 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00293 |
Epithelial discoidin domain-containing receptor 1 |
phosphorylation |
Tyr796 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00294 |
Sodium-dependent phosphate transporter 2 |
phosphorylation |
Tyr377 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00295 |
Syntaxin-4 |
phosphorylation |
Tyr115 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00296 |
Unconventional myosin-Ie |
phosphorylation |
Tyr961 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00297 |
Unconventional myosin-Ie |
phosphorylation |
Tyr7 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00298 |
Unconventional myosin-Ie |
phosphorylation |
Tyr989 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00299 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 |
phosphorylation |
Tyr500 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00300 |
GRB2-associated-binding protein 1 |
phosphorylation |
Tyr406 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|